FOXP3 and colorectal carcinoma: Further, CTLA-4 was identified on subsets of Treg cells, where high expression of CTLA-4 was revealed along with a significant increase of activated Tregs (CD45R Foxp3+ T cells) in the blood and tissues of CRC patients (69).